Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 6/6 |
Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for 002173 from our risk checks.
Innovative Medical Management Co.,Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CN¥6.41 |
52 Week High | CN¥10.68 |
52 Week Low | CN¥5.88 |
Beta | 0.61 |
11 Month Change | -0.47% |
3 Month Change | -23.60% |
1 Year Change | -31.44% |
33 Year Change | -3.17% |
5 Year Change | 0.79% |
Change since IPO | -48.86% |
Recent News & Updates
Shareholder Returns
002173 | CN Healthcare | CN Market | |
---|---|---|---|
7D | -0.5% | -1.6% | -1.6% |
1Y | -31.4% | -32.5% | -19.6% |
Return vs Industry: 002173 exceeded the CN Healthcare industry which returned -32.5% over the past year.
Return vs Market: 002173 underperformed the CN Market which returned -19.6% over the past year.
Price Volatility
002173 volatility | |
---|---|
002173 Average Weekly Movement | 6.3% |
Healthcare Industry Average Movement | 4.7% |
Market Average Movement | 5.7% |
10% most volatile stocks in CN Market | 9.0% |
10% least volatile stocks in CN Market | 3.8% |
Stable Share Price: 002173's share price has been volatile over the past 3 months.
Volatility Over Time: 002173's weekly volatility (6%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1997 | 2,633 | Jianjian Ma | www.chxyl.com |
Innovative Medical Management Co.,Ltd. engages in the medical services business in China. The company owns and operates Jianhua Hospital, Kanghua Hospital, Futian Hospital, and Mingzhu Hospital.
Innovative Medical Management Co.,Ltd. Fundamentals Summary
002173 fundamental statistics | |
---|---|
Market cap | CN¥2.83b |
Earnings (TTM) | -CN¥46.86m |
Revenue (TTM) | CN¥808.30m |
3.5x
P/S Ratio-60.4x
P/E RatioIs 002173 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
002173 income statement (TTM) | |
---|---|
Revenue | CN¥808.30m |
Cost of Revenue | CN¥727.07m |
Gross Profit | CN¥81.23m |
Other Expenses | CN¥128.10m |
Earnings | -CN¥46.86m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -0.11 |
Gross Margin | 10.05% |
Net Profit Margin | -5.80% |
Debt/Equity Ratio | 3.6% |
How did 002173 perform over the long term?
See historical performance and comparison